The following relates generally to medical devices and techniques and more particularly to an eyelid manipulation device for use during treatment of eyelids and eyes.
Radio Frequency (RF) is an aesthetic technique that uses radio frequency energy to heat skin to regenerate collagen and elastin to reduce the appearance of forehead wrinkles, frown lines, crow's feet, and smile lines. An off-label procedure is to use RF to reduce dry eye symptoms by heating the Meibomian glands located in the upper and lower lids. Meibomian glands are oil-producing glands that help protect the tears from evaporation. When they become clogged or if they are not functioning properly, the eye suffers from a degenerative disease called Meibomian Gland Dysfunction (MGD), which is often associated with dry eye syndrome.
Commonly, RF application to reduce dry-eye symptoms involves using an RF hand piece to apply penetrative heat and vibration to the Meibomian glands, providing mechanical expression and stimulation of the glands. Protocol for RF treatment for MGD requires a corneal shield placed under the upper and lower lids to protect the cornea from heat and potential contact injury from the downward pressure of the RF hand piece.
United States Patent Application Publication No. 2017/0071790 to Grenon et al. discloses methods and apparatuses for treatment of MGD.
United States Patent Application Publication No. 2020/0069468 to Litherland et al. discloses devices and methods for treating eyelids and expressing occlusions in the Meibomian glands of the eyelids.
Current corneal shields proposed for dry eye treatment tend to have a number of shortcomings. For example, they tend to be produced in one-size-fits-all format, and to be expensive. Furthermore, current corneal shields, due to their bulk and their large size relative to the treatment region and space between eyelids, can be difficult to insert between the eyelid and the globe. Once finally in place, current corneal shields can be difficult to manipulate, and can accordingly be uncomfortable for a patient because when manipulation is attempted they can easily inadvertently pinch skin of the eyelid. Furthermore, due to their bulk with respect to the size of the eye, it can be difficult to work on specific regions of an eyelid—for example to manually target counter pressure to facilitate expression of the Meibomian glands in a particular treatment region. In addition, due to their limited mobility once positioned between the eyelid and the eyeball, it can be difficult to manipulate current corneal shields to treat lid margins.
It is an object of the following description to address the disadvantages referred to above.
According to an aspect of this description, there is provided an eyelid manipulation device comprising: a rigid contact portion dimensioned to be insinuated between an eyelid and a globe, the contact portion having an upwardly-facing surface opposite a downwardly-facing surface, each of the surfaces extending between a distal side and a proximal side of the contact portion; and a rigid stem integral with and extending upwardly from the proximal side of the contact portion.
In an embodiment, at least the exterior of the eyelid manipulation device is made of at least one non-conductive material.
In an embodiment, the at least one non-conductive material comprises a medical grade material.
In an embodiment, the at least one medical grade material is selected from the group consisting of silicone and polyethylene.
In an embodiment, the stem is connectable to a handle.
According to another aspect, there is provided an eyelid manipulation system comprising: the eyelid manipulation device; and an elongate handle removably connectable to the rigid stem.
In an embodiment, at least the exterior of the handle is formed of at least one non-conducting material.
According to another aspect, there is provided a use of the eyelid manipulation system for treatment of Meibomian glands.
According to another aspect, there is provided a use of the eyelid manipulation system for treatment of dry eye symptoms.
In an embodiment of the eyelid manipulation device, the stem is elongated, thereby serving as a handle. The elongated stem eyelid manipulation device may itself be used for treatment of Meibomian glands, and/or for treatment of dry eye symptoms.
Other aspects and advantages will be apparent upon reading the following.
Embodiments of the invention will now be described with reference to the appended drawings in which:
In this embodiment, at least the exterior of the eyelid manipulation device is made of one or more non-conductive materials, such as medical grade silicone, medical grade polymer such as polyethylene, and/or some other material. Other non-conductive materials may be used provided that they are appropriate in an eyelid manipulation device such as is disclosed herein. The non-conductive material resists transfer of heat emitted from a radiofrequency treatment device or another heat treatment device that is incident on eyelid manipulation device 10 through to the eyelid EL, globe G, a cheek or other feature of the person whose eyelids are being treated via eyelid manipulation device 10. In embodiments, a core or backbone of the eyelid manipulation device, or components thereof, might be made of a conductive material that is itself coated with a non-conductive material, thereby to provide an exterior that resists the heat transfer to the person being treated. It will be appreciated that although a coated conductive core eyelid manipulation device could be useful for providing rigidity while sufficiently resisting such heat transfer, such a device could be more complex to manufacture than an eyelid manipulation device made or molded from a single material.
Furthermore, in this embodiment at least the exterior of handle 20 is formed of a non-conductive material, such that an eyelid manipulation system 5 comprising eyelid manipulation device 10 and handle 20, as a whole, can resist transfer of any heat to the person being treated.
In this description, rigidity refers to contact portion 12 and stem 17 being generally inflexible with respect to each other during manipulation, so that manipulative force imparted via handle 10 to stem 17 translates predictably for a user to corresponding force applied via contact portion 12 to the region of the eyelid EL to be manipulated. It is to be understood that there may be some flexibility or yield to material that may coat the surfaces of at least the contact portion of the EMD—such as medical grade silicone. Furthermore, EMD 10 may be flexible or bendable upon application of an amount of force that significantly exceeds that generally imparted to eyelid manipulation device 10 when it is insinuated between an eyelid EL and a globe G and is being used to manipulate eyelid EL. Therefore, while eyelid manipulation device 10 might be deliberately flexed or bent if desired and if its material permits, it is to be understood that it is useful for handle 20, stem 17 and contact portion 12 to behave, during and for the purpose of manipulation, as a single generally-inflexible unit so that the user's delicate manipulations of handle 20 are translated predictably into just as delicate manipulations of contact portion 12.
In this embodiment, EMD 10 is sized and shaped to be insinuated between an eyelid EL and globe G, so that the eyelid EL can be manipulated in various ways during a treatment while the underlying globe G is being shielded by EMD 10 from any incident radiation. Such manipulation may include lifting eyelid EL at selected locations along eyelid EL thereby to lift eyelid EL out of a rest position (which is against globe G) to which eyelid EL is normally biased. Lifting eyelid EL against its bias imparts pressure on the underside of eyelid EL, which pressure—particularly when targeted using EMD 10—can be useful for assisting with manipulating Meibomian glands as explained above.
Contact portion 12 of EMD 10 is generally narrower between its left and right sides with respect to globe G than are corneal shields disclosed in the prior art. This enables a user to focus on a particular region of eyelid EL for manipulation at any given time. Furthermore, contact portion 12 and stem 17 are arranged with respect to each other to permit EMD 10 to be used to manipulate individual regions of just one eyelid EL (of two associated with a given eye) at a time. In particular, stem 17 of EMD 10—and accordingly handle 20 with which it is connected during use—extends from the proximal end of contact region 12, rather than from a top surface as in known corneal shields. For example, known corneal shields having a handle extending from the top surface of a corneal shield leave a portion of the corneal shield behind the handle. This portion of the corneal shield behind the handle can interfere with an edge of an eyelid while the user's focus is on the other eyelid, potentially pinching the eyelid. In contrast, EMD 10 and handle 20 of
Contact portion 12 of EMD 10 is of sufficient thickness to serve as a corneal RF shield, thereby to sufficiently shield a globe G from incident RF radiation and/or heat that may be applied to eyelid EL from above. In this embodiment, stem 17 is also sufficient to provide some shielding should the RF radiation and/or heat be incident on stem 17.
In this embodiment, the upwardly-facing surface 13 of contact portion 12 is the surface intended to contact the underside of an eyelid EL, and is convex both along the distal-proximal direction (right to left in
Handle 20 facilitates single hand operation, freeing the other hand to manipulate an RF treatment device or other device while EMD 10 is being held and manipulated using handle 20. The operability of handle 20 allows for greater facilitation, specifically in the areas surrounding the eyelid margin, which is critical in the effective treatment of Meibomian gland expression. The enhanced operability over conventional solutions decreases the overall time of Meibomian gland treatment and discomfort for the patient.
It will be understood that the size of an emmetropic adult eye is approximately 24.2 mm (transverse, horizontal)×23.7 mm (sagittal, vertical)×22.0-24.8 mm (axial, anteroposterior) with minimal difference between sex and age. In the transverse diameter, the eyeball size may vary from 21 mm to 27 mm. It will be understood that myopia and hypermetropia change the axial diameter significantly leading to variance ranging from 20 to 26 mm.
In this embodiment, the contact portion of EMD 10 has a transverse diameter of 30 mm, thereby to be larger than a human eye, thus reducing the potential for the edges to become the point of contact during normal use. A tip width of 20 mm provides a wide enough surface to facilitate eyelid expression without compromising comfort of the patient.
In this embodiment, handle 20 is generally triangular in cross-section—with slightly rounded edges. The generally triangular shape cross-section first widens and then tapers along the length from distal end to proximal end. Handles with different cross sectional shapes such as those that are the same cross-sectional size from distal end to proximal end, may alternatively be used. Handles having longer or shorter lengths may be used. An elongate handle of the relative size shown can be useful, since a user of EMD 10 may wish to hold handle 20 near its proximal end, near its distal end, or somewhere in between, in order to manipulate in different ways for a given treatment or in different ways for different treatments. In embodiments, handle 20 may be coated with a material helpful for improving manual grip, such as medical grade silicone and/or some other material suitable in a medical context. Polyethylene may be considered.
It will be appreciated from the drawings that the interfaces between the various sides and surfaces are rounded sufficiently so that EMD 10 does not present sharp corners or edges to the eyelid and eye during use.
In embodiments described above, handle 20 and EMD 10 are not integral, so that they can be connected for use and then separated, with the EMD 10 potentially being disposed of without necessarily having to dispose of handle 20. In this way, handle 20 can be re-used, and the EMDs 10 can be disposed of after a given use. This also enables one handle to be used with various different thicknesses or other configurations of EMDs.
EMDs with different thicknesses may be provided. For example, EMDs with contact portions having smaller or larger thicknesses may be chosen by a user for a particular application and/or as a preference. For example, the maximum thickness of the contact portion of a given EMD may be 1.00 mm, 1.25 mm, 1.5 mm, 1.75 mm, or larger or smaller sizes. One factor in the thickness will be the ease with which the contact portion 12 can be inserted between eyelid EL and globe G. Another will be the utility of the corneal shielding that contact portion 12 can provide. For example, if the material of a given contact portion 12 is dense, or particularly suited to shielding from RF radiation, it may be thinner than another contact portion of another EMD made of a material that is not very dense or otherwise suited to shielding at small thicknesses. In addition, a contact portion of an EMD may be coated with a material that is both excellent for RF shielding as well as suitable for use in a medical context, thereby to supplement the shielding provided by the underlying contact portion.
In use, a user such as a medical practitioner inserts the stem of an EMD 10 into a handle 20 in interference fit, checks the fit, and then with the aid of handle 20 gently slides the distal end 16 of EMD 10 between an eyelid EL and the globe G beneath it. The eyelid EL and globe G may have previously been treated with an appropriate lubricant. With EMD 10 having been inserted between the eyelid EL and globe G, the user can then slightly lift eyelid EL by slightly pulling EMD 10 away from the globe G using handle 20. Then, if the user wishes, he or she can slide EMD 10 back and forth underneath the eyelid EL to target manipulation to particular regions of the eyelid EL, and can draw the eyelid EL away from the globe G in any of these regions thereby to focus sufficient pressure on the underside of the eyelid EL in the selected region. The user can then apply RF radiation to the other side of the eyelid region thereby to treat the Meibomian glands. The user can also gently move an EMD 10 from side to side and front to back, as desired, in order to impart pressure on the region in different ways and in different amounts, thereby to effect gland expression. The user may wish to twist handle 20 slightly to, via EMD 10, apply edge pressure to the underside of the eyelid EL in the selected region, if desired, while accordingly adjusting the position of the source of RF radiation thereby to ensure that the globe G continues to be sufficiently shielded.
Although embodiments have been described with reference to the drawings, those of skill in the art will appreciate that variations and modifications may be made without departing from the spirit, scope and purpose of the invention as defined by the appended claims.
For example, while in embodiments described the surfaces of the contact portion are arced in both the distal-proximal and left-right directions, alternatives are possible in which the arcing is in only one of these directions. Furthermore, provided edges and corners are rounded, an alternative contact portion might have generally planar upwardly facing and/or downwardly facing surfaces.
Furthermore, alternatives in which the stem is elongated and thus itself serves as an integral handle are possible. The stem may, along its length, change in cross-sectional shape thereby to serve more suitably as a stem at the proximal end of the rigid contact portion, and more suitably as a handle as it extends away from the rigid contact portion.
For example,
This application claims priority to U.S. Provisional Patent Application Ser. No. 63/130,542 filed on Dec. 24, 2020, the contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63130542 | Dec 2020 | US |